Iradimed Co (IRMD) — Cash Flow-to-Debt Ratio
Iradimed Co (IRMD) has a Cash Flow-to-Debt Ratio of 0.52x as of March 2026, meaning its operating cash flow of $8.29 Million could theoretically repay 1% of its total liabilities ($15.88 Million) in one year. See Iradimed Co (IRMD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Iradimed Co Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Iradimed Co across 14 annual periods. Also explore Iradimed Co equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Iradimed Co (2012–2025)
Year-by-year debt coverage analysis for Iradimed Co. For market capitalisation and broader financial context, see Iradimed Co (IRMD) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.76x | $24.95 Million | $14.16 Million | ▼ -20.9% |
| 2024 | 2.23x | $25.62 Million | $11.51 Million | ▲ +242.9% |
| 2023 | 0.65x | $13.47 Million | $20.74 Million | ▼ -23.4% |
| 2022 | 0.85x | $10.04 Million | $11.84 Million | ▼ -19.3% |
| 2021 | 1.05x | $11.26 Million | $10.71 Million | ▲ +75.0% |
| 2020 | 0.60x | $5.82 Million | $9.68 Million | ▼ -34.2% |
| 2019 | 0.91x | $10.23 Million | $11.20 Million | ▼ -19.6% |
| 2018 | 1.14x | $7.38 Million | $6.50 Million | ▲ +102.1% |
| 2017 | 0.56x | $3.42 Million | $6.08 Million | ▼ -68.3% |
| 2016 | 1.77x | $9.41 Million | $5.31 Million | ▼ -23.3% |
| 2015 | 2.31x | $7.65 Million | $3.31 Million | ▲ +116.1% |
| 2014 | 1.07x | $2.59 Million | $2.42 Million | ▲ +13.4% |
| 2013 | 0.94x | $1.47 Million | $1.56 Million | ▲ +45.8% |
| 2012 | 0.65x | $1.51 Million | $2.33 Million | — |